Press Releases about Merck & Co
Via MarketBeat
Topics
Artificial Intelligence
From Merck & Co., Inc.
Via Business Wire
From Merck & Co., Inc.
Via Business Wire
Merck Provides Update on Phase 3 Trials KEYNOTE-641 and KEYNOTE-789
February 28, 2023
From Merck & Co., Inc.
Via Business Wire
MarketBeat Week in Review – 2/6 - 2/10
February 11, 2023
Via MarketBeat
Should Investors Buy or Sell the Vaccinex Patent News?
February 07, 2023
Via MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.